June 25, 2019 – top 20 success stories other than myself (2019)

Other · Joe Tippens (publishing other patients' stories) · June 25, 2019

Joe Tippens (publishing other patients' stories), 2019-06-25: A later collection of twenty patient stories with the doses individual patients used – including a jumpstart of nine straight days then 3-on/4-off, and a double dose for three weeks before the standard 222 mg – with outcomes ranging from no evidence of disease to tumour reduction without total elimination.

Started with a double dose 7 days a week for 3 weeks and then the recommended 222mg dose 7 days a week for 9 weeks, then all clear NED

Post body (unpaginated)

Joe Tippens (publishing other patients' stories), 2019-06-25: A later collection of twenty patient stories with the doses individual patients used – including a jumpstart of nine straight days then 3-on/4-off, and a double dose for three weeks before the standard 222 mg – with outcomes ranging from no evidence of disease to tumour reduction without total elimination. Patient-reported, not independently verified. Stories as published, anonymised: Ewing sarcoma with brain and spine metastases ('jumpstart of 9 straight days, then pulsed 3 on and 4 off for 14 weeks… all clear NED'); oesophageal cancer with liver metastases (double dose 7 days a week for 3 weeks, then 222 mg daily for 9 weeks, NED); two stage IV melanomas (8 and 7 months to NED); triple-negative breast cancer with lung, node and brain metastases (brain MRI clear at 10 weeks); lung adenocarcinoma (NED at 14 weeks); two prostate cancers (NED at 4 and 3 months). No patient identifiers, no scan reports, no independent verification, and no denominators – the number who tried and did not respond is not stated. No funder or conflict statement. Study type: other.